COMPANY · NIPC 500113270

FERRAZ LYNCE SA

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €9,969,027.09 across 643 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameFERRAZ LYNCE SA
NIPC500113270

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2026. The table below gives the same values.2012: €882,079.2220122013: €133,220.832014: €76,223.5420142015: €135,221.452016: €178,297.7420162017: €756,196.862018: €1,515,590.7320182019: €2,675,880.012020: €1,059,495.6520202021: €430,213.122022: €1,191,590.1820222023: €296,485.662024: €193,843.2120242025: €400,159.492026: €44,529.402026€2,675,880.01
Contracted value by year
YearContractsContract value
201213€882,079.22
20137€133,220.83
201425€76,223.54
201520€135,221.45
201619€178,297.74
201726€756,196.86
201847€1,515,590.73
201956€2,675,880.01
202061€1,059,495.65
202168€430,213.12
202246€1,191,590.18
202352€296,485.66
202464€193,843.21
202567€400,159.49
202672€44,529.40
Contracted value by place of performance
NameContractsContract value
Setúbal27€3,520,433.49
Faro40€1,874,454.07
Coimbra28€1,111,009.19
Lisboa75€1,009,900.46
Évora12€866,429.97
Braga12€66,190.94
Almada24€56,206.42
Amadora17€55,850.64
Santarém11€48,245.79
Vila Nova de Gaia18€40,134.46
Largest contracts
SubjectYearContract value
procedimento n.o 050100012019 com base no CPA 2015/122018€969,990.79
Vários medicamentos2022€765,161.78
AQUISIÇÃO DE MEDICAMENTOS DO APARELHO RESPIRATÓRIO-20192019€599,026.44
41/386/2019 - 31 Medicamentos do Aparelho Respiratório2019€580,930.41
61001919- Medicamentos Apareho Respiratorio_SPMS AMINOFILINA,225MG,COMP LP AMINOFILINA,240MG/10ML SOL INJ FR 10ML IV BECLOMETASONA 50MCG SOL PRESSU INAL RECIP PRESSU FR 200 DOSES BECLOMETASONA 250MCG SOL PRESSU INAL RECIP PRESSU FR 200 DOSE2019€504,575.91

Who they competed with

In 2,990 contracts with a list of competitors, the company took part and was awarded 205 (7%).

Companies with the most procedures in common
CompanyProcedures in common
generis farmaceutica SA261
overpharma244
medinfar242
mylan236
sandoz209
labesfal, sa182
pfizer152
farmoz152
hikma lda149
angelini129
b.braun medical101
Novartis Farma, SA96
Logifarma - Logistica Farmacêutica S.A.96
unilfarma94
glaxo89
astrazeneca87
Bluepharma, S.A.84
fresenius kabi pharma82
spcare80
teva71
Zentiva, Lda.70
pharmakern65
Baxter Médico farmacêutica63
Laboratórios Normon, SA61
sanofi59
gsk54
DLA-Farmacêutica,SA.51
accord46
prospa43
bAYER42

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents38 companies and 60 links. The list below gives the same content as text.bAYER (NIPC 500043256)bAYERNovartis Farma… (NIPC 500063524)Novartis Farma…NIPC 500113270 (NIPC 500113270)NIPC 500113270sanofi (NIPC 500134960)sanofiglaxo (NIPC 500139962)glaxopfizer (NIPC 500162166)pfizerunilfarma (NIPC 500293023)unilfarmamedinfar (NIPC 500384045)medinfarangelini (NIPC 500583650)angelinilabesfal, sa (NIPC 501169580)labesfal, safarmoz (NIPC 501505334)farmoz+27 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.